Company news
Codexis, Inc. (NASDAQ:CDXS) news
Codexis, Inc. news releases on 6ix. Latest, Sep 28, 2026: Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis…
Press releases & updates
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
September 28, 2026
Codexis to Participate in Cantor Global Healthcare Conference 2026
August 27, 2026
Codexis Reports Second Quarter 2026 Financial Results
August 11, 2026
Codexis Appoints David Butler, PhD, to Strategic Advisory Board
August 3, 2026
Codexis to Report Second Quarter 2026 Financial Results on August 11
July 28, 2026
Codexis Announces Proposed Public Offering of Common Stock - July 23, 2026
July 27, 2026
Codexis Announces Pricing of Public Offering of Common Stock - July 23, 2026
July 27, 2026
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
May 20, 2026
Codexis Reports First Quarter 2026 Financial Results
May 7, 2026
Codexis to share RNA manufacturing advances at TIDES USA
April 29, 2026
Codexis to Report First Quarter 2026 Financial Results on May 7
April 23, 2026
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
March 10, 2026
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
March 4, 2026
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
February 24, 2026
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
February 17, 2026
Codexis Achieves ISO 9001:2015 Certification
February 10, 2026
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
January 6, 2026
Codexis Announces Signing of Lease for GMP Manufacturing Facility
November 9, 2025
Codexis Reports Third Quarter 2025 Financial Results
November 5, 2025
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
October 28, 2025
Codexis to Report Third Quarter 2025 Financial Results on November 6
October 22, 2025
Codexis to Participate in Cantor Global Healthcare Conference
August 27, 2025
Codexis Reports Second Quarter 2025 Financial Results
August 12, 2025
Switch Bioworks Expands Leadership Team and Moves into New Facility to Accelerate Development of its Microbial Fertilizer Products
August 7, 2025
Codexis to Report Second Quarter 2025 Financial Results on August 13
July 29, 2025
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
May 21, 2025
Codexis to Participate in Jefferies Global Healthcare Conference
May 20, 2025
Codexis Reports First Quarter 2025 Financial Results
May 13, 2025
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
May 6, 2025
Codexis to Report First Quarter 2025 Financial Results on May 14
April 29, 2025
Codexis Announces Byron Dorgan to Retire from Board of Directors
April 8, 2025
Codexis Appoints Cynthia Collins to Board of Directors
March 31, 2025
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
March 23, 2025
Codexis Announces New Employment Inducement Grants
March 6, 2025
Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results
February 26, 2025
Codexis to Participate in TD Cowen 45th Annual Health Care Conference
February 17, 2025
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
February 12, 2025
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
February 5, 2025
Codexis Appoints Christos Richards to Board of Directors
January 15, 2025
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
November 18, 2024
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
November 13, 2024
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
November 11, 2024
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
November 10, 2024
Codexis to Participate in Upcoming Healthcare Conferences
November 3, 2024
Codexis Reports Third Quarter 2024 Financial Results
October 30, 2024
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
October 23, 2024
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
October 21, 2024
Codexis to Report Third Quarter 2024 Financial Results on October 31
October 9, 2024
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
October 1, 2024
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
September 30, 2024